Literature DB >> 6294260

Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

P C Burger, P J Dubois, S C Schold, K R Smith, G L Odom, D C Crafts, F Giangaspero.   

Abstract

Pathological findings in 20 cases of glioblastoma multiforme were correlated with clinical histories and computerized tomographic (CT) scans. This was done to define the neoplasm in three stages: before treatment, during remission, and during recurrence. The untreated lesions were markedly cellular neoplasms composed predominantly of small anaplastic cells. The radiographic central region of low density was necrosis, the enhancing rim was a cellular zone of viable neoplasm, and the perilesional low-density area was edema with infiltrating tumor. In these 20 cases, all of the identifiable neoplasms lay within the zone of peritumoral edema or contrast enhancement, although small anaplastic cells may have been present in more distant regions. The lesions in remission were remarkable for their minimal mass effect, discrete nature, extensive necrosis, and content of large bizarre glia. The large cells were confined to the original tumor bed and were consistent with neoplastic cells inactivated and immobilized by radio- and chemotherapy. These lesions were accurately localized by CT scanning. The recurrent lesions were heterogeneous, but most were formed of widely disseminated small anaplastic cells. The highly cellular regions of such lesions could be localized by CT scanning, but CT could not detect less cellular foci in the cerebrum, cerebellum, or brain stem. In one patient, the contrast-enhancing lesions of "recurrence," were foci of radionecrosis, underscoring the difficulty in distinguishing this entity from recurrent neoplasm.

Entities:  

Mesh:

Year:  1983        PMID: 6294260     DOI: 10.3171/jns.1983.58.2.0159

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  101 in total

1.  Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.

Authors:  Stella Blasel; Kea Franz; Hanns Ackermann; Stefan Weidauer; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurooncol       Date:  2010-10-07       Impact factor: 4.130

Review 2.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 3.  Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?

Authors:  Yaacov Richard Lawrence; Deborah T Blumenthal; Diana Matceyevsky; Andrew A Kanner; Felix Bokstein; Benjamin W Corn
Journal:  J Neurooncol       Date:  2011-04-24       Impact factor: 4.130

Review 4.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

5.  Optimal control strategies of eradicating invisible glioblastoma cells after conventional surgery.

Authors:  Aurelio A de Los Reyes V; Eunok Jung; Yangjin Kim
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

6.  Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Authors:  J Sherriff; J Tamangani; L Senthil; G Cruickshank; D Spooner; B Jones; C Brookes; P Sanghera
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

7.  Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.

Authors:  Hong Rye Kim; Se-Hwan Kim; Jung-Il Lee; Ho Jun Seol; Do-Hyun Nam; Sung Tae Kim; Kwan Park; Jong Hyun Kim; Doo-Sik Kong
Journal:  J Neurooncol       Date:  2014-12-09       Impact factor: 4.130

8.  Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.

Authors:  M Matsutani; O Nakamura; M Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; K Ueki; Y Tanaka
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas.

Authors:  M Matsutani; O Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; M Nakamura; K Ueki; Y Tanaka; T Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases.

Authors:  M Scerrati; P Montemaggi; M Iacoangeli; R Roselli; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.